APA (7th ed.) Citation

Sugitani, Y., Nishida, A., Inatomi, O., Ohno, M., Imai, T., Kawahara, M., . . . Andoh, A. (2020). Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease. Journal of gastroenterology, 55(4), 408-417. https://doi.org/10.1007/s00535-019-01660-z

Chicago Style (17th ed.) Citation

Sugitani, Yoshihiko, Atsushi Nishida, Osamu Inatomi, Masashi Ohno, Takayuki Imai, Masahiro Kawahara, Kenichiro Kitamura, and Akira Andoh. "Sodium Absorption Stimulator Prostasin (PRSS8) Has an Anti-inflammatory Effect via Downregulation of TLR4 Signaling in Inflammatory Bowel Disease." Journal of Gastroenterology 55, no. 4 (2020): 408-417. https://doi.org/10.1007/s00535-019-01660-z.

MLA (9th ed.) Citation

Sugitani, Yoshihiko, et al. "Sodium Absorption Stimulator Prostasin (PRSS8) Has an Anti-inflammatory Effect via Downregulation of TLR4 Signaling in Inflammatory Bowel Disease." Journal of Gastroenterology, vol. 55, no. 4, 2020, pp. 408-417, https://doi.org/10.1007/s00535-019-01660-z.